15901-51-6 Usage
Description
Ethyl 3-methylisothiazole-4-carboxylate is a chemical compound that belongs to the family of isothiazole derivatives. It is characterized by its strong, fruity odor with citrus and tropical fruit notes, making it a popular choice as a fragrance ingredient in various personal care products and household goods. This versatile chemical also serves as a flavoring agent in food and beverages, imparting a sweet, fruity flavor. Furthermore, its antimicrobial properties contribute to the preservation and extension of the shelf life of consumer products.
Uses
Used in Fragrance Industry:
Ethyl 3-methylisothiazole-4-carboxylate is used as a fragrance ingredient for its strong, fruity odor with citrus and tropical fruit notes. It is employed to impart a fresh and clean scent to products such as soaps, shampoos, and detergents.
Used in Flavor Industry:
In the flavor industry, ethyl 3-methylisothiazole-4-carboxylate is used as a flavoring agent, adding a sweet, fruity flavor to food and beverages.
Used in Preservation Industry:
Ethyl 3-methylisothiazole-4-carboxylate is utilized for its antimicrobial properties, making it useful in preserving and extending the shelf life of consumer products.
Check Digit Verification of cas no
The CAS Registry Mumber 15901-51-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,5,9,0 and 1 respectively; the second part has 2 digits, 5 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 15901-51:
(7*1)+(6*5)+(5*9)+(4*0)+(3*1)+(2*5)+(1*1)=96
96 % 10 = 6
So 15901-51-6 is a valid CAS Registry Number.
15901-51-6Relevant articles and documents
Discovery of (+)-N-(3-aminopropyl)-N-[1-(5-benzyl-3-methyl-4-oxo-[1,2] thiazolo[5,4- d ]pyrimidin-6-yl)-2-methylpropyl]-4-methylbenzamide (AZD4877), a kinesin spindle protein inhibitor and potential anticancer agent
Theoclitou, Maria-Elena,Aquila, Brian,Block, Michael H.,Brassil, Patrick J.,Castriotta, Lillian,Code, Erin,Collins, Michael P.,Davies, Audrey M.,Deegan, Tracy,Ezhuthachan, Jayachandran,Filla, Sandra,Freed, Ellen,Hu, Haiqing,Huszar, Dennis,Jayaraman, Muthusamy,Lawson, Deborah,Lewis, Paula M,Nadella, Murali V. P.,Oza, Vibha,Padmanilayam, Maniyan,Pontz, Timothy,Ronco, Lucienne,Russell, Daniel,Whitston, David,Zheng, Xiaolan
, p. 6734 - 6750 (2011/12/04)
Structure-activity relationship analysis identified (+)-N-(3-aminopropyl)- N-[1-(5-benzyl-3-methyl-4-oxo-[1,2]thiazolo[5,4-d]pyrimidin-6-yl) -2-methylpropyl]-4-methylbenzamide (AZD4877), from a series of novel kinesin spindle protein (KSP) inhibitors, as exhibiting both excellent biochemical potency and pharmaceutical properties suitable for clinical development. The selected compound arrested cells in mitosis leading to the formation of the monopolar spindle phenotype characteristic of KSP inhibition and induction of cellular death. A favorable pharmacokinetic profile and notable in vivo efficacy supported the selection of this compound as a clinical candidate for the treatment of cancer.